Ropeginterferon Alfa-2B
Ropeginterferon alfa-2b is a novel mono-pegylated proline-interferon alfa-2b with antiviral and antiproliferative properties, used for the treatment of polycythemia vera and chronic hepatitis C. It acts by binding to cell surface receptors to activate the JAK-STAT signaling pathway, suppressing viral replication and abnormal cell proliferation. Its extended half-life allows for less frequent dosing compared to conventional interferons.
Molekularmasse
447,5000 g/mol
LogP
-1,30
TPSA
136,00 Ų
Lipinski-Regel der Fünf
Bestanden
Therapeutische Bereiche
Pharmacokinetics (PK)
Pharmacodynamics (PD)
SMILES
COCCOC(=O)NCCCCC(CCN1CCC[C@H]1C(=O)O)NC(=O)OCCOC
InChI
InChI=1S/C20H37N3O8/c1-28-12-14-30-19(26)21-9-4-3-6-16(22-20(27)31-15-13-29-2)8-11-23-10-5-7-17(23)18(24)25/h16-17H,3-15H2,1-2H3,(H,21,26)(H,22,27)(H,24,25)/t16?,17-/m0/s1
Molecular Formula
C20H37N3O8
HBD / HBA
3 / 9
Rotierbare Bindungen
18
Schwere Atome
31
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Häufig gestellte Fragen
Ropeginterferon alfa-2b is a novel mono-pegylated proline-interferon alfa-2b with antiviral and antiproliferative properties, used for the treatment of polycythemia vera and chronic hepatitis C. It acts by binding to cell surface receptors to activate the JAK-STAT signaling pathway, suppressing viral replication and abnormal cell proliferation. Its extended half-life allows for less frequent dosing compared to conventional interferons.
Yes, Ropeginterferon Alfa-2B is an approved drug. It has reached clinical phase 4. It is classified as a Protein.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4297819. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 86278347. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="ropeginterferon-alfa-2b"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/ropeginterferon-alfa-2b/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/ropeginterferon-alfa-2b/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/ropeginterferon-alfa-2b/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="ropeginterferon-alfa-2b"></drugfyi-drug>